Determination of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol with Gas Chromatography-Mass Spectrometry: Analytical and Preanalytical Challenges and Pitfalls
Medical Cannabis and Cannabinoids · 2018
DOI: 10.1159/000489032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Cannabis and Cannabinoids, 2018. Verfasst von Christian Lanz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, University of Bern, Bern, Switzerland. Die Arbeit wurde bisher 19-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The endocannabinoids anandamide (N-arachidonoyl ethanolamide [AEA]) and 2-arachidonoyl glycerol (2-AG) are involved in the regulation of neuronal, immune, metabolic, vascular, and reproductory functions.
Methods
The development and validation of an analytical method for the determination of AEA and 2-AG in human plasma based on liquid-liquid extraction and gas chromatography-mass spectrometry after silylation is described and (pre)-analytical pitfalls are identified.
Results
In contrast to 2-AG, AEA was unstable in whole blood and increased by a factor of 2.3 within 3 h on ice. AEA was stable in plasma on ice for 4 h while 2-AG tended to decrease. Excellent stability at room/ambient temperature was found for both derivatized compounds over 45 h. Furthermore, 3 freeze-thaw cycles revealed a complex pattern: endogenous AEA was stable in plasma but slightly increased in spiked samples (+12.8%), while endogenous 2-AG concentrations increased by 51% and declined by 24% in spiked samples. A long-term study over 4 weeks at –80°C showed that low endogenous AEA and spiked 2-AG concentrations were stable. However, spiked AEA tended to increase (+19%) and endogenous 2-AG significantly increased by 50% after 2 weeks. Food intake 2 h before blood collection showed no effect on AEA concentrations, whereas 2-AG increased significantly by a factor of 3.
Conclusions
Overall, limited in vitro and/or in vivo/ex vivo chemical stability of endocannabinoids has to be taken into account.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Research, University of Bern, Bern, Switzerland.
- Center of Laboratory Medicine, University Institute of Clinical Chemistry, University Hospital Inselspital Bern, Bern, Switzerland.
- Clinic for Visceral Surgery and Medicine, University Hospital Inselspital Bern, Bern, Switzerland.
- Hepatology, Department of Clinical Research, University of Bern, Bern, Switzerland.
Zitieren
APA
Lanz, C., Mattsson, J., Stickel, F., Dufour, J. F., & Brenneisen, R. (2018). Determination of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol with Gas Chromatography-Mass Spectrometry: Analytical and Preanalytical Challenges and Pitfalls. Medical Cannabis and Cannabinoids. https://doi.org/10.1159/000489032
Vancouver
Lanz C, Mattsson J, Stickel F, Dufour JF, Brenneisen R. Determination of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol with Gas Chromatography-Mass Spectrometry: Analytical and Preanalytical Challenges and Pitfalls. Medical Cannabis and Cannabinoids. 2018. doi:10.1159/000489032
BibTeX
@article{Lanz2018,
author = {Lanz, Christian and Mattsson, Johan and Stickel, Felix and Dufour, Jean-Francois and Brenneisen, Rudolf},
title = {Determination of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol with Gas Chromatography-Mass Spectrometry: Analytical and Preanalytical Challenges and Pitfalls},
journal = {Medical Cannabis and Cannabinoids},
year = {2018},
doi = {10.1159/000489032}
}
EUVIMED